Multiple sclerosis arises from a combination of genes and environment. It has abundant clinical symptoms, varied clinical courses, and probably different histopathological subtypes. In the past 10 years, 6 therapies that partially treat MS have been developed, and more are likely to be approved in the near future.
Multiple sclerosis, histopathology, treatment
HAMAMCIOĞLU, KEMAL and REDER, ANTHONY T. (2005) "Current Perspectives in the Pathogenesis and Treatment of Multiple Sclerosis," Turkish Journal of Medical Sciences: Vol. 35: No. 3, Article 1. Available at: https://journals.tubitak.gov.tr/medical/vol35/iss3/1